Literature DB >> 7655009

Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation.

M Hoffman1, D M Monroe, J A Oliver, H R Roberts.   

Abstract

Tissue factor is the major initiator of coagulation. Both factor IX and factor X are activated by the complex of factor VIIa and tissue factor (VIIa/TF). The goal of this study was to determine the specific roles of factors IXa and Xa in initiating coagulation. We used a model system of in vitro coagulation initiated by VIIa/TF and that included unactivated platelets and plasma concentrations of factors II, V, VIII, IX, and X, tissue factor pathway inhibitor, and antithrombin III. In some cases, factor IX and/or factor X were activated by tissue factor-bearing monocytes, but in some experiments, picomolar concentrations of preactivated factor IX or factor X were used to initiate the reactions. Timed samples were assayed for both platelet activation and thrombin activity. Factor Xa was 10 times more potent than factor IXa in initiating platelet activation, but factor IXa was much more effective in promoting thrombin generation than was factor Xa. In the presence of VIIa/TF, factor X was required for both platelet activation and thrombin generation, while factor IX was only required for thrombin generation. We conclude that VIIa/TF-activated factors IXa and Xa have distinct physiologic roles. The main role of factor Xa that is initially activated by VIIa/TF is to activate platelets by generating an initial, small amount of thrombin in the vicinity of platelets. Factor IXa, on the other hand, enhances thrombin generation by providing factor Xa on the platelet surface, leading to prothrombinase formation. Only tiny amounts of factors IX and X need to be activated by VIIa/TF to perform these distinct functions. Our experiments show that initiation of coagulation is highly dependent on activation of small amounts of factors IXa and Xa in proximity to platelet surfaces and that these factors play distinct roles in subsequent events, leading to an explosion of thrombin generation. Furthermore, the specific roles of factors IXa and Xa generated by VIIa/TF are not necessarily reflected by the kinetics of factor IXa and Xa generation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7655009

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

Review 1.  Links between the immune and coagulation systems: how do "antiphospholipid antibodies" cause thrombosis?

Authors:  M Hoffman; D M Monroe; R A Roubey
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 2.  Translating nucleic acid aptamers to antithrombotic drugs in cardiovascular medicine.

Authors:  Thomas J Povsic; Bruce A Sullenger; Steven L Zelenkofske; Christopher P Rusconi; Richard C Becker
Journal:  J Cardiovasc Transl Res       Date:  2010-11-16       Impact factor: 4.132

Review 3.  New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin.

Authors:  Shannon M Bates; Jeffrey I Weitz
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

4.  Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively.

Authors:  Mikhail A Panteleev; Mikhail V Ovanesov; Dmitrii A Kireev; Aleksei M Shibeko; Elena I Sinauridze; Natalya M Ananyeva; Andrey A Butylin; Evgueni L Saenko; Fazoil I Ataullakhanov
Journal:  Biophys J       Date:  2005-12-02       Impact factor: 4.033

5.  Anticoagulant therapy during cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-10-19       Impact factor: 2.300

6.  Brazilian propolis (AF-08) inhibits collagen-induced platelet aggregation without affecting blood coagulation.

Authors:  Chihiro Sugita; Atsushi Yamashita; Shigetoshi Tsutsumi; Hisahiro Kai; Tohru Sonoda; Hiroki Yoshida; Ryuichi Yamamoto; Yujiro Asada; Masahiko Kurokawa
Journal:  J Nat Med       Date:  2021-05-04       Impact factor: 2.343

7.  Measurement of procoagulant platelet subpopulations in whole blood: development of an assay for population-based studies.

Authors:  Beth A Bouchard; Aimee K Paradis; Kathleen E Brummel-Ziedins
Journal:  Thromb Res       Date:  2010-06-11       Impact factor: 3.944

Review 8.  Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery.

Authors:  Robert J Porte; Frank W G Leebeek
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.

Authors:  Y Buyue; T M Misenheimer; J P Sheehan
Journal:  J Thromb Haemost       Date:  2012-10       Impact factor: 5.824

Review 10.  Thrombin generation, fibrin clot formation and hemostasis.

Authors:  Alisa S Wolberg; Robert A Campbell
Journal:  Transfus Apher Sci       Date:  2008-02-20       Impact factor: 1.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.